Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News Cotinga Pharmaceuticals Inc COTQF

Healthcare Biotechnology
Cotinga Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company's lead clinical candidate, COTI-2, is an oral small molecule targeting p53, a tumor suppressor gene that is mutated in over 50% of all cancers, and the company's second clinical candidate, COTI-219, is a novel oral small molecule compound targeting the mutant forms of KRAS with such mutations occurring in up... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (GREY:COTQF)

IIROC Trading Halt - COT

Canada NewsWire October 15, 2020

IIROC Trading Resumption - COT

Canada NewsWire November 7, 2019

IIROC Trading Halt - COT

Canada NewsWire October 7, 2019

Cotinga Pharmaceuticals Releases Additional Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

GlobeNewswire July 18, 2019

Cotinga Pharmaceuticals Doses First Patient in Third Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

GlobeNewswire June 27, 2019

Cotinga Pharmaceuticals Announces Initiation of Next Cohort of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

GlobeNewswire June 5, 2019

Cotinga Pharmacueticals Announces Closing of Second Tranche of Unit Offering

GlobeNewswire June 4, 2019

Cotinga Pharmacueticals Announces Closing of Unit Offering

GlobeNewswire May 22, 2019

Cotinga Pharmaceuticals Releases Early Interim Data of Phase 1b/2a Combination Trial of COTI-2 in Solid Tumors

GlobeNewswire May 8, 2019
View More News ››

Opinion & Analysis (GREY:COTQF)

Canadian Biotech comes back to life: A buyer's guide

Tony Pullen January 21, 2014
View More Opinion ››

Bullboard Posts (GREY:COTQF)

What's going on here.....

Absolutely nothing imo
zzstocks70 - June 5, 2021

RE:RE:RE:Any news?

Up and down like GME!!
Farmer9 - January 28, 2021

RE:RE:Any news?

How is it trading in the states still?
HutchHouse2021 - January 10, 2021

RE:Any news?

You find out anything on Cotinga? They have disappeared but stock shows $0.035 with no halted sign. Very strange
HutchHouse2021 - January 10, 2021

Any news?

Any update on trials at MD Anderson, Dublin? Are they still talking to pharmas??
Sauderfarm - January 28, 2020

back trading

TSX-Venture Symbol: COT (all issues) Resumption (ET): 9:30 AM  November 8, 2019 IIROC can make a decision to impose a...
jcjohn36 - November 11, 2019
View more Bullboard ››

Silver Range Resources Ltd

Silver Range Resources Ltd

Silver Range Resources Ltd. is a Canada-based mineral exploration company. The Company’s mineral property interests include ...
View More »